Advertisement

Journal of General Internal Medicine

, Volume 28, Issue 2, pp 208–215 | Cite as

Differential Impact of Longitudinal Medication Non-Adherence on Mortality by Race/Ethnicity among Veterans with Diabetes

  • Leonard E. EgedeEmail author
  • Cheryl P. Lynch
  • Mulugeta Gebregziabher
  • Kelly J. Hunt
  • Carrae Echols
  • Gregory E. Gilbert
  • Patrick D. Mauldin
Original Research

ABSTRACT

OBJECTIVE

To examine the differential effect of medication non-adherence over time on all-cause mortality by race/ethnicity.

RESEARCH DESIGN AND METHODS

Data on a longitudinal cohort of veterans with type 2 diabetes was examined. The main outcome was time to death. Primary independent variables were race/ethnicity and mean medication possession ratio (MPR) categorized into quintiles over the study period. Cox regression was used to model the association between time to death and MPR quintiles and race/ethnicity, adjusting for relevant covariates.

RESULTS

The cohort of 629,563 veterans was followed for 5 years. After adjusting for all covariates, the hazard ratios (HR) for subjects in the lowest versus highest MPR quintile was 12.21 (95 % CI 11.89, 12.55) for non-Hispanic white (NHW), 10.01 (95 % CI 9.18, 10.91) for non-Hispanic black (NHB), 12.65 (95 % CI 11.10, 14.43) for Hispanic and 10.41 (95 % CI 9.06, 11.96) for Other race veterans. Furthermore, type of diabetes therapy (oral versus insulin) maintained a significant relationship with mortality that varied by racial/ethnic group.

CONCLUSIONS

This study demonstrates the differential impact of medication non-adherence on mortality by race. It also demonstrates that type of diabetes therapy (insulin with or without oral agents) is associated with mortality and varies by racial/ethnic group.

KEY WORDS

medication non-adherence veterans diabetes mortality race/ethnicity 

Notes

Acknowledgements

Funders

This study was supported by grant #IIR-06-219 funded by the VHA Health Services Research and Development (HSR&D) program. The funding agency did not participate in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. The manuscript represents the views of the authors and not those of the VA or HSR&D. All authors had access to the data and contributed to the manuscript

Conflict of Interest

The authors declare that they do not have a conflict of interest.

Supplementary material

11606_2012_2200_MOESM1_ESM.pdf (132 kb)
ESM 1 (PDF 131 kb)

REFERENCES

  1. 1.
    Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008.Google Scholar
  2. 2.
    Xu JQ, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: Final data for 2007. National vital statistics reports; vol 58 no 19. Hyattsville, MD: National Center for Health Statistics. 2010. Available online: http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_19.pdf. Accessed August 3, 2012.
  3. 3.
    Mokdad, A.. Diabetes trends in the U.S.: 1990–1998. Diabetes Care. 2000;23(9): 1278–83. [PMID: 10977060].Google Scholar
  4. 4.
    Cowie C. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999–2002. Diabetes Care. 2006;29(6):1263–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Adams AS, Trinacty CM, Zhang F, et al. Medication adherence and racial differences in A1C control. Diabetes Care. 2008;31(5):916–21.PubMedCrossRefGoogle Scholar
  6. 6.
    Grant R, Adams AS, Trinacty CM, et al. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care. 2007;30(4):807–12.PubMedCrossRefGoogle Scholar
  7. 7.
    Trinacty CM, Adams AS, Soumerai SB, et al. Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study. BMC Health Serv Res. 2009;9:24.PubMedCrossRefGoogle Scholar
  8. 8.
    Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care. 2004;27(9):2149–53.PubMedCrossRefGoogle Scholar
  9. 9.
    Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–41.PubMedCrossRefGoogle Scholar
  10. 10.
    Heisler M, Choi H, Rosen AB, et al. Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis. Med Care. 2010;48(2):87–94.PubMedGoogle Scholar
  11. 11.
    Kuo YF, Raji MA, Markides KS, Ray LA, Espino DV, Goodwin JS. Inconsistent use of diabetes medications, diabetes complications, and mortality in older Mexican Americans over a 7-year period: data from the Hispanic established population for the epidemiologic study of the elderly. Diabetes Care. 2003;26(11):3054–60.PubMedCrossRefGoogle Scholar
  12. 12.
    Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003;25(11):2958–71.PubMedCrossRefGoogle Scholar
  13. 13.
    Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care. 2004;27(Suppl 2):B10–21.PubMedCrossRefGoogle Scholar
  14. 14.
    West AN, Lee RE, Shambaugh-Miller MD, et al. Defining “rural” for veterans’ health care planning. J Rural Health. Fall;26(4):301–9. [PMID: 21029164].Google Scholar
  15. 15.
    Department of Veterans Affairs Field Research Advisory Committee. (2004). Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Field Research Advisory Committee Operating Procedures. Available online: http://www.research.va.gov/about/frac/FRAC-ops.pdf Accessed August 3, 2012.
  16. 16.
    SAS statistical software, version 9.2. SAS Institute Inc, Cary, NC.Google Scholar
  17. 17.
    Cramer JA, Benedict A, Muszbek N, et al. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract. 2008;62:76–87.PubMedCrossRefGoogle Scholar
  18. 18.
    Hertz RP, Unger AN, Lustik MB. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Clin Ther. 2005;27(7):1064–73.PubMedCrossRefGoogle Scholar
  19. 19.
    Lynch CP, Gebregziabher M, Echols C, Gilbert GE, Zhao Y, Egede LE. Racial Disparities in All-Cause Mortality Among Veterans with Type 2 Diabetes. J Gen Intern Med. Jun 8 2010. [PMID: 20532659].Google Scholar
  20. 20.
    Jha AK, Shlipak MG, et al. (2001). “Racial differences in mortality among men hospitalized in the Veterans Affairs health care system.” JAMA. Jan 17 2001;285(3): 297–303. [PMID: 11176839].Google Scholar
  21. 21.
    Volpp KG, Stone R, Lave JR, et al. Is thirty-day hospital mortality really lower for black veterans compared with white veterans? Health Serv Res. 2007;42(4):1613–31.PubMedCrossRefGoogle Scholar
  22. 22.
    Cramer JA, Pugh MJ. The influence of insulin use on glycemic control: how well do adults follow prescriptions for insulin? Diabetes Care. 2005;28:78–83.PubMedCrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2012

Authors and Affiliations

  • Leonard E. Egede
    • 1
    • 2
    Email author
  • Cheryl P. Lynch
    • 1
    • 2
  • Mulugeta Gebregziabher
    • 1
    • 3
  • Kelly J. Hunt
    • 1
    • 3
  • Carrae Echols
    • 1
  • Gregory E. Gilbert
    • 1
  • Patrick D. Mauldin
    • 2
    • 4
    • 5
  1. 1.Center for Disease Prevention and Health Interventions for Diverse Populations, Ralph H Johnson Veterans Affairs Medical CenterCharlestonUSA
  2. 2.Center for Health Disparities ResearchMedical University of South CarolinaCharlestonUSA
  3. 3.Division of Biostatistics & EpidemiologyMedical University of South CarolinaCharlestonUSA
  4. 4.Department of MedicineMedical University of South CarolinaCharlestonUSA
  5. 5.Division of General Internal Medicine & GeriatricsCharlestonUSA

Personalised recommendations